Robert MD - Traws Pharma Acting Officer

All Insiders . USA . 
Stock . Traws Pharma . Stakeholders . Insider . Robert MD
TRAW Stock   4.58  0.16  3.38%   

Executive

Robert MD is Acting Officer of Traws Pharma
Age 73
Address 12 Penns Trail, Newtown, PA, United States, 18940
Phone267 759 3680
Webhttps://www.trawspharma.com

Traws Pharma Management Efficiency

The company has return on total asset (ROA) of (0.5251) % which means that it has lost $0.5251 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (10.9652) %, meaning that it created substantial loss on money invested by shareholders. Traws Pharma's management efficiency ratios could be used to measure how well Traws Pharma manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.88 in 2024. Return On Capital Employed is likely to drop to -1.58 in 2024. At this time, Traws Pharma's Total Assets are fairly stable compared to the past year. Other Current Assets is likely to climb to about 1.9 M in 2024, whereas Non Currrent Assets Other are likely to drop 855.00 in 2024.

Similar Executives

Showing other executives

EXECUTIVE Age

Harout DiramerianHudson Pacific Properties
49
Matthew YoungTreasury Wine Estates
N/A
William MulrowJBG SMITH Properties
64
Erik ThoreenHudson Pacific Properties
N/A
Eunice WongHudson Pacific Properties
N/A
Charles HaldemanJBG SMITH Properties
72
Steven JDHudson Pacific Properties
62
Evan ReganLevineJBG SMITH Properties
N/A
Alberto ParederoQuirosSNDL Inc
51
Lisa BurelliHudson Pacific Properties
N/A
Phyllis CaldwellJBG SMITH Properties
61
Sophie PilonSNDL Inc
N/A
Matthew HussonSNDL Inc
43
Wolf WirthHudson Pacific Properties
N/A
Scott EstesJBG SMITH Properties
50
Jim SoutterHudson Pacific Properties
N/A
Alan FormanJBG SMITH Properties
54
Ryan KarchnerHudson Pacific Properties
N/A
John WoodJBG SMITH Properties
48
A JacksonJBG SMITH Properties
N/A
Phil McBrideSNDL Inc
N/A
Traws Pharma (TRAW) is traded on NASDAQ Exchange in USA. It is located in 12 Penns Trail, Newtown, PA, United States, 18940 and employs 17 people. Traws Pharma was previously known as Onconova Therapeutics and was traded on NASDAQ Exchange under the symbol ONTX. Traws Pharma is listed under Pharmaceuticals category by Fama And French industry classification.

Management Performance

Return On Equity-10.97
Return On Asset-0.53

Traws Pharma Leadership Team

Elected by the shareholders, the Traws Pharma's board of directors comprises two types of representatives: Traws Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Traws. The board's role is to monitor Traws Pharma's management team and ensure that shareholders' interests are well served. Traws Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Traws Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
Robert MD, Acting Officer
DPHIL MA, Executive Chairman
Mark CPA, Chief Officer
Victor MD, Chief Oncology
Steven MD, President Oncology
Nikolay Savchuk, COO Director
Charles Pauza, Chief Virology
Werner Cautreels, CEO Director
C Pauza, Chief Virology

Traws Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Traws Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-10.97
Return On Asset-0.53
Operating Margin(103.23) %
Current Valuation(8.03 M)
Shares Outstanding25.31 M
Shares Owned By Insiders14.62 %
Shares Owned By Institutions11.40 %
Number Of Shares Shorted10.35 K
Price To Book1.67 X
Price To Sales39.17 X

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C

Additional Tools for Traws Stock Analysis

When running Traws Pharma's price analysis, check to measure Traws Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Traws Pharma is operating at the current time. Most of Traws Pharma's value examination focuses on studying past and present price action to predict the probability of Traws Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Traws Pharma's price. Additionally, you may evaluate how the addition of Traws Pharma to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY